Novo Nordisk takes over Inversago Pharma Inc.
With a US$1bn acquisition of Canadian Inversago Pharma, Novo Nordisk A/S fiights to maintain its dominant position in the booming weight loss drug market.
ADVERTISEMENT
About Thomas Gabrielczyk
This author has not written his bio yet.
But we are proud to say that Thomas Gabrielczyk contributed 1996 entries already.
Entries by Thomas Gabrielczyk
Promising viral gene therapy for genetic kidney disease
British researchers have proven that a new gene can prevent progression of hereditary kidney damage in mice.
Alianza Team invests in microbial oil maker Clean Food Group
Lipid, nutrition and frozen bakery specialist Allianza Team puts £900,500 into pre-Series A financing of microbial palm oil producer Clean Food Group Ltd.
More marine plastics than expected
A Dutch-German team of researchers has found out that the amount of not degradable plastics is lower than estimated but that they persist for longer than previously assumed.
Sygnature Discovery Ltd acquires leading Canadian CRO
British drug discovery specialist Sygnature Discovery Ltd has taken over Canadian NuChem Sciences Inc., one of North Americas largest discovery CROs
Enzyme foams morer active and stable
Researchers at the Karlsruhe Institute of Technology (KIT) have transformed enzymes into a new form: as foams, the biocatalysts prove to be extremely stable and active.
Bavarian Nordic A/S bags US$120m for smallpox vaccine
Bavarian Nordic A/S will get US$120m from a contract for the manufacturing of smallpox and mpox vaccine from the US government.
PureTech Health gets US$11.4m to advance LYT-300
LSE-listed PureTech Health plc hat been granted p to US$11.4m from U.S. Department of Defense to advance LYT-300 to treat Fragile X-associated tremor/ataxia syndrome.
Neuraxpharm pays US$650m for MS drug commercialisation
TG Therapeutics will receive US$140m upfront from German Neuraxpharm for Ex-US commercialisation rights of its deglycosylated anti-CD20 antibody ublituximab-xiiy.
Mithra Pharmaceuticals SA in €17m licencing deal
Mithra and Searchlight Pharma have inked a licensing deal for Donesta commercialisation in Canada.